Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zymeworks Inc.

    NASDAQ: ZYME · Real-Time Price · USD
    14.18
    -0.18 (-1.25%)
    At close: Aug 18, 2025, 1:41 PM
    -1.25%
    Bid 14.15
    Market Cap 1.07B
    Revenue (ttm) 93.38M
    Net Income (ttm) -113.68M
    EPS (ttm) -0.98
    PE Ratio (ttm) -14.47
    Forward PE -11.13
    Analyst Buy
    Ask 14.18
    Volume 190,996
    Avg. Volume (20D) 486,162.1
    Open 14.37
    Previous Close 14.36
    Day's Range 13.96 - 14.68
    52-Week Range 9.03 - 17.70
    Beta 1.26

    About ZYME

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ZYME
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ZYME stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Zymeworks Inc. is scheduled to release its earnings on Oct 30, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    5 months ago
    -7.97%
    Zymeworks shares are trading lower after the compa... Unlock content with Pro Subscription
    8 months ago
    +9.46%
    Zymeworks shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and announced a price target of $18.
    news image

    5 days ago · zacks.com

    Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

    Zymeworks (ZYME) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a t...

    news image

    1 week ago · seekingalpha.com

    Zymeworks Inc. (ZYME) Q2 2025 Earnings Call Transcript

    Zymeworks Inc. (NASDAQ:ZYME ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Kenneth H. Galbraith - Chairman of the Board, CEO & President Leone D.

    news image

    1 week ago · zacks.com

    Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates

    Zymeworks Inc. (ZYME) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.52 per share. This compares to a loss of $0.26 per share a year ago.

    news image

    1 month ago · zacks.com

    Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?

    Zymeworks (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r...

    news image

    1 month ago · zacks.com

    All You Need to Know About Zymeworks (ZYME) Rating Upgrade to Buy

    Zymeworks (ZYME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    2 months ago · seekingalpha.com

    Zymeworks: Early-Stage Biotech Feel Despite Zanidatamab Advancements (Downgrade)

    Zymeworks Inc.'s lead asset zanidatamab won FDA approval for HER2-positive biliary tract cancer, validating its platform but addressing a small market. The main investment thesis hinges on upcoming Ph...

    news image

    2 months ago · zacks.com

    Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High?

    The consensus price target hints at a 76.7% upside potential for Zymeworks (ZYME). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat...

    Add to Watchlist